Use of a desferrioxamine "microdose" to chelate aluminum in hemodialysis patients.
作者信息
Jorge C, Gil C, Possante M, Catarino M C, Cruz A, Andrade R, Teixeira R, Santos N, Ferreira A
出版信息
Clin Nephrol. 1999 Nov;52(5):335-6.
PMID:10585000
Abstract
摘要
相似文献
1
Use of a desferrioxamine "microdose" to chelate aluminum in hemodialysis patients.使用去铁胺“微剂量”螯合血液透析患者体内的铝。
Clin Nephrol. 1999 Nov;52(5):335-6.
2
Effect of desferrioxamine on aluminum kinetics during hemodialysis.去铁胺对血液透析期间铝动力学的影响。
Miner Electrolyte Metab. 1984;10(4):263-6.
3
Desferrioxamine in the treatment of aluminum overload.去铁胺治疗铝过载。
Clin Nephrol. 1985;24 Suppl 1:S94-7.
4
Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
Pediatrics. 1986 Oct;78(4):651-5.
5
Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration.
Am J Kidney Dis. 2000 Nov;36(5):969-75. doi: 10.1053/ajkd.2000.19098.
6
[Verification of desferrioxamine ototoxicity by high-frequency audiometry in patients undergoing dialysis].[通过高频听力测定法验证接受透析患者去铁胺的耳毒性]
An Otorrinolaringol Ibero Am. 1994;21(2):193-8.
7
Ultrafiltrable aluminium after very low doses of desferrioxamine.
Nephrol Dial Transplant. 1998 Jun;13(6):1538-42. doi: 10.1093/ndt/13.6.1538.
8
Continuous ambulatory EEG monitoring following desferrioxamine (DFO) i.v. infusion.静脉输注去铁胺（DFO）后进行动态脑电图监测。
Trans Am Soc Artif Intern Organs. 1985;31:546-51.
9
Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.去铁胺给药后尿毒症血清中铝去铁胺和铁去铁胺的比例较低。
Clin Chem. 1998 Jun;44(6 Pt 1):1262-8.
10
Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.去铁胺治疗后铝性脑病加重。
Nephrol Dial Transplant. 1989;4(7):676.
Zotero 插件